The US salmon farming industry can now benefit from the proven health and nutritional benefits of krill. As of June 10th, the Food and Drug Administration (FDA) has approved QRILL™ AQUA and QRILL™ High Protein meal for use in salmon feeds.

Oslo, June 15, 2022: After 10 years in the making and undergoing a comprehensive process, Aker BioMarine has received approval from the FDA for the use of its QRILL Aqua and QRILL High Protein (QHP) products in freshwater and marine salmonids.

Since Aker BioMarine's krill products contain astaxanthin, a natural source of red color that may enhance the color of salmon flesh, the FDA classified it as a color additive. The approval of products under this classification is very thorough and krill meal as an ingredient in fish feeds has been subjected to extensive evaluation by FDA during the approval process.

This has been a goal for Aker BioMarine and the fish farming industry for many years, as it is very important for the salmon industry in North America to obtain access to sustainable, safe and highly nutritious ingredients for their feeds.

"We have been waiting for this approval for a long time and are very excited to see this come to life," said Sigve Nordrum, EVP Animal Health and Nutrition, Aker BioMarine. "We serve the aquaculture industry across the globe and now we are excited to do the same in North America. For years, feed companies and fish farmers in this region were well aware of the benefits of krill for fish feeds and salmon, therefore they have been demanding these products for their North American operations. We look forward to working with our customers in this market to support the production of high quality, sustainable and healthy fish."

Made from Antarctic krill, Aker BioMarine's QRILL Aqua functions as a feeding stimulant leading to increased feed uptake and enhanced growth. QRILL Aqua is also proven to improve health, stress tolerance and fillet quality.

QRILL High Protein is a protein rich product used in formulated diets for aquaculture nutrition. It is an excellent source of marine protein for fish and shrimp, leading to increased feed uptake and enhanced growth.

About Aker BioMarine

Aker BioMarine is a biotech innovator and Antarctic krill-harvesting company, dedicated to improving human and planetary health. Listed on Oslo Stock Exchange, the company develops krill-based ingredients for pharmaceutical, nutraceutical (Superba®, NKO® and K·REAL®), aquaculture (QRILL™ Aqua), and animal feed applications (QRILL™ Pet), including INVI™, a highly concentrated protein isolate, and LYSOVETA™, a targeted transporter of EPA and DHA from krill. Aker BioMarine's fully transparent value chain stretches from sustainable krill harvesting in pristine Antarctic waters through its Montevideo logistics hub, Houston production plant, and to customers around the world. The company's strong focus on sustainability inspired the launch of AION by Aker BioMarine, a circularity company dedicated to helping companies to recycle and reuse waste. Read more: www.akerbiomarine.com

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Aker BioMarine ASA published this content on 15 June 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 15 June 2022 09:12:10 UTC.